Eastman Chemical CO Form 4 insider transactions

Eastman Chemical Co.'s CEO, Mark J. Costa, reports acquisition of shares and stock options, including employee stock options and restricted stock units, as per a recent SEC filing.

Christopher Moore Killian, SVP, CTO & Sust. Ofc of Eastman Chemical Co, reports acquisition of stock options and restricted stock units.

Michelle Renee Stewart, Controller & CAO of Eastman Chemical Co, reports the acquisition of stock options and restricted stock units.

EVP & CCO of Eastman Chemical, Brad Lich, reports acquisition and disposal of common stock related to performance share payout and tax liability.

Stephen Glenn Crawford, an Executive Vice President at Eastman Chemical Co, reports changes in his beneficial ownership of company stock due to the payout of performance shares and subsequent tax liability.

SVP, Chf HR Ofcr Adrian James Holt reports acquisition of 2,734 shares and disposal of 697 shares of Eastman Chemical Co common stock on February 18, 2025.

CEO Mark Costa reports acquisition of 81,525 shares and disposal of 30,638 shares of Eastman Chemical Co. stock on February 18, 2025.

Michelle H. Caveness, SVP & Chief Manufacturing Officer of Eastman Chemical Co, reports the payout of performance shares and subsequent tax liability coverage through withheld shares.

William Thomas McLain Jr., EVP and CFO of Eastman Chemical Co., reports the acquisition and disposal of company stock related to performance share payouts and tax obligations.

Christopher M. Killian, SVP, CTO & Sust. Ofc at Eastman Chemical Co, reports acquisition and disposal of common stock related to performance share payout and tax liability.

Brian Travis Smith, an Executive Vice President at Eastman Chemical Co., reported the acquisition and disposal of common stock on February 18, 2025, following the payout of performance shares and withholding for tax liabilities.

Julie A. McAlindon, SVP at Eastman Chemical Co, reports acquisition and disposal of common stock related to performance share payout and tax liability.

Michelle Renee Stewart, Controller & CAO of Eastman Chemical Co, reports acquisition and disposal of common stock on February 18, 2025, according to a Form 4 filing.

Eastman Chemical's CEO, Mark J. Costa, exercised stock options and sold the resulting shares on November 29, 2024.

Adrian James Holt, SVP and Chief HR Officer at Eastman Chemical Co., sold 3,683 shares of common stock after the vesting of restricted stock units.

Eastman Chemical's EVP & CCO, Brad A. Lich, exercised stock options and sold shares in multiple transactions, as detailed in a recent SEC filing.

An Eastman Chemical executive, Stephen Glenn Crawford, exercised stock options and sold shares on November 27, 2024.

Julie A. McAlindon, SVP at Eastman Chemical Co., exercised stock options and sold shares on November 26, 2024.

Eastman Chemical's CEO, Mark J. Costa, exercised stock options and sold shares on November 26, 2024.

An Eastman Chemical executive, Stephen Glenn Crawford, sold shares after exercising stock options, according to a recent SEC filing.

Christopher M. Killian, SVP & CTO of Eastman Chemical Co., sold 3,061 shares of common stock at $105 per share on November 6, 2024, according to a Form 4 filing.

Director Brett D. Begemann reports acquisition of phantom stock units through deferral of director's fees.

Director Donald W. Slager reports changes in beneficial ownership of Eastman Chemical Co stock due to deferred compensation and dividend reinvestment.

Director James J. O'Brien reports acquisition of phantom stock units through deferral of director's fees.

Director Kim Ann Mink reports acquisition of phantom stock units through Eastman Chemical Co's Directors' Deferred Compensation Plan.

Director Julie Fasone Holder reports acquisition of phantom stock units through deferral of director's fees and dividend equivalents.

Director David W. Raisbeck reports acquisition of phantom stock units through deferral of director's fees.

Director Humberto P. Alfonso increased his holdings in Eastman Chemical Co through the acquisition of phantom stock units via deferral of director's fees.

Director Eric L. Butler reports changes in beneficial ownership of Eastman Chemical Co stock due to deferred compensation and dividend reinvestments.

Director Linnie M. Haynesworth reports acquisition of phantom stock units through deferral of director's fees.